Waylon Weber, PhD, to present findings on a Neurological Protection Study at the Society Of Toxicology Annual Meeting and Tox Expo.
Lovelace Biomedical’s Chief Scientific Officer, Jake McDonald, PhD, is chosen to join a National Academy of Sciences Panel.
Cell and Gene Therapy World
January 22-25; Miami, FL
February 12-14; Baltimore, MD
Biocom Global Life Science Partnering Conference
February 28-March 1; La Jolla, CA
SOT 57th Annual Meeting and ToxExpo
March 11-15; San Antonio, TX
American Society of Gene and Cell Therapy 2018 Annual Meeting
May 16-19; Chicago, IL